Cargando…
The Role of Translocator Protein TSPO in Hallmarks of Glioblastoma
SIMPLE SUMMARY: The translocator protein (TSPO) has been under extensive investigation as a specific marker in positron emission tomography (PET) to visualize brain lesions following injury or disease. In recent years, TSPO is increasingly appreciated as a potential novel therapeutic target in cance...
Autores principales: | Ammer, Laura-Marie, Vollmann-Zwerenz, Arabel, Ruf, Viktoria, Wetzel, Christian H., Riemenschneider, Markus J., Albert, Nathalie L., Beckhove, Philipp, Hau, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602186/ https://www.ncbi.nlm.nih.gov/pubmed/33066460 http://dx.doi.org/10.3390/cancers12102973 |
Ejemplares similares
-
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages
por: Weidner, Lorraine, et al.
Publicado: (2023) -
TSPO acts as an immune resistance gene involved in the T cell mediated immune control of glioblastoma
por: Menevse, Ayse N., et al.
Publicado: (2023) -
Tumor Cell Invasion in Glioblastoma
por: Vollmann-Zwerenz, Arabel, et al.
Publicado: (2020) -
Efficacy of D,L-methadone in the treatment of glioblastoma in vitro
por: Brawanski, Konstantin, et al.
Publicado: (2018) -
Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
por: Braun, Frank K., et al.
Publicado: (2023)